# A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

> **NCT04274894** · PHASE4 · COMPLETED · sponsor: **AbbVie** · enrollment: 246 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** AndroGel 1.62%

## Key facts

- **NCT ID:** NCT04274894
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-12
- **Primary completion:** 2021-12-07
- **Final completion:** 2022-01-07
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04274894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04274894, "A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04274894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*